{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T22:27:03Z","timestamp":1793831223013,"version":"4.6.1"},"reference-count":35,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,13]],"date-time":"2024-05-13T00:00:00Z","timestamp":1715558400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["heartrhythmopen.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heart Rhythm O2"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.hroo.2024.05.003","type":"journal-article","created":{"date-parts":[[2024,5,17]],"date-time":"2024-05-17T14:48:45Z","timestamp":1715957325000},"page":"341-350","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Safety of outpatient commencement of sotalol"],"prefix":"10.1016","volume":"5","author":[{"given":"Suraya H.","family":"Kamsani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa E.","family":"Middeldorp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Glenda","family":"Chiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Stefil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaun","family":"Evans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mau T.","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elnaz","family":"Shahmohamadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica Qingying","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kurt C.","family":"Roberts-Thomson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehrdad","family":"Emami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Glenn D.","family":"Young","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3803-8429","authenticated-orcid":false,"given":"Prashanthan","family":"Sanders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.hroo.2024.05.003_bib1","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/S0002-8703(97)70186-8","article-title":"Multicenter comparative study of the efficacy and safety of sotalol in the prophylactic treatment of patients with paroxysmal supraventricular tachyarrhythmias","volume":"133","author":"Wanless","year":"1997","journal-title":"Am Heart J"},{"key":"10.1016\/j.hroo.2024.05.003_bib2","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.120.020506","article-title":"Comparative safety and effectiveness of sotalol versus dronedarone after catheter ablation for atrial fibrillation","volume":"11","author":"Wharton","year":"2022","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.hroo.2024.05.003_bib3","doi-asserted-by":"crossref","first-page":"51a","DOI":"10.1016\/0002-9149(93)90025-8","article-title":"Usefulness of sotalol for life-threatening ventricular arrhythmias","volume":"72","author":"Roden","year":"1993","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.hroo.2024.05.003_bib4","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1056\/NEJM199308123290702","article-title":"A comparison of seven antiarrhythmic drugs in patients with ventricular tachyarrhythmias","volume":"329","author":"Mason","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hroo.2024.05.003_bib5","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/0002-9149(91)90013-B","article-title":"Usefulness of d,l-sotalol for suppression of chronic ventricular arrhythmias","volume":"67","author":"Anastasiou-Nana","year":"1991","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.hroo.2024.05.003_bib6","article-title":"Antiarrhythmics for maintaining sinus rhythm after cardioversion of atrial fibrillation","volume":"9","author":"Valembois","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.hroo.2024.05.003_bib7","doi-asserted-by":"crossref","first-page":"A27","DOI":"10.1016\/0002-9149(93)90022-5","article-title":"Pharmacologic basis of the antiarrhythmic and hemodynamic effects of sotalol","volume":"72","author":"Antonaccio","year":"1993","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.hroo.2024.05.003_bib8","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1161\/01.CIR.81.2.686","article-title":"Class III antiarrhythmic agents have a lot of potential but a long way to go: reduced effectiveness and dangers of reverse use dependence","volume":"81","author":"Hondeghem","year":"1990","journal-title":"Circulation"},{"key":"10.1016\/j.hroo.2024.05.003_bib9","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1093\/europace\/eut153","article-title":"QT variability during initial exposure to sotalol: experience based on a large electronic medical record","volume":"15","author":"Weeke","year":"2013","journal-title":"Europace"},{"key":"10.1016\/j.hroo.2024.05.003_bib10","doi-asserted-by":"crossref","first-page":"74A","DOI":"10.1016\/0002-9149(90)90207-H","article-title":"Clinical safety profile of sotalol in patients with arrhythmias","volume":"65","author":"Soyka","year":"1990","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.hroo.2024.05.003_bib11","doi-asserted-by":"crossref","first-page":"2535","DOI":"10.1161\/01.CIR.94.10.2535","article-title":"Sex difference in risk of torsade de pointes with d,l-sotalol","volume":"94","author":"Lehmann","year":"1996","journal-title":"Circulation"},{"key":"10.1016\/j.hroo.2024.05.003_bib12","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/0167-5273(92)90257-4","article-title":"Efficacy and safety of sotalol in patients with complex ventricular arrhythmias","volume":"37","author":"Hohnloser","year":"1992","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.hroo.2024.05.003_bib13","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0735-1097(98)00189-2","article-title":"Is hospital admission for initiation of antiarrhythmic therapy with sotalol for atrial arrhythmias required? Yield of in-hospital monitoring and prediction of risk for significant arrhythmia complications","volume":"32","author":"Chung","year":"1998","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hroo.2024.05.003_bib14","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0002-9149(02)03378-7","article-title":"Risk of proarrhythmia with class III antiarrhythmic agents: sex-based differences and other issues","volume":"91","author":"Wolbrette","year":"2003","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.hroo.2024.05.003_bib15","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1056\/NEJMoa041705","article-title":"Amiodarone versus sotalol for atrial fibrillation","volume":"352","author":"Singh","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hroo.2024.05.003_bib17","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1111\/jce.15342","article-title":"Economics and outcomes of sotalol in-patient dosing approaches in patients with atrial fibrillation","volume":"33","author":"Varela","year":"2022","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.1016\/j.hroo.2024.05.003_bib18","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1345\/aph.1L698","article-title":"Cost of hospital admission for antiarrhythmic drug initiation in atrial fibrillation","volume":"43","author":"Kim","year":"2009","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.hroo.2024.05.003_bib19","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1007\/s40256-021-00493-7","article-title":"Outpatient initiation of sotalol in patients with atrial fibrillation: utility of cardiac implantable electronic devices for therapy monitoring","volume":"21","author":"Mascarenhas","year":"2021","journal-title":"Am J Cardiovasc Drugs"},{"key":"10.1016\/j.hroo.2024.05.003_bib20","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1016\/j.hrthm.2023.08.019","article-title":"Mortality and ventricular arrhythmias in patients on d,l-sotalol for rhythm control of atrial fibrillation: a nationwide cohort study","volume":"20","author":"Lenhoff","year":"2023","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hroo.2024.05.003_bib21","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1016\/j.hrthm.2014.08.026","article-title":"New formula for evaluation of the QT interval in patients with left bundle branch block","volume":"11","author":"Bogossian","year":"2014","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hroo.2024.05.003_bib22","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1056\/NEJMra032426","article-title":"Drug-induced prolongation of the QT interval","volume":"350","author":"Roden","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hroo.2024.05.003_bib23","doi-asserted-by":"crossref","first-page":"281","DOI":"10.7326\/0003-4819-127-4-199708150-00004","article-title":"Risk of initiating antiarrhythmic drug therapy for atrial fibrillation in patients admitted to a university hospital","volume":"127","author":"Maisel","year":"1997","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.hroo.2024.05.003_bib24","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/j.ehj.2004.04.015","article-title":"Prevention of atrial fibrillation after cardioversion: results of the PAFAC trial","volume":"25","author":"Fetsch","year":"2004","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hroo.2024.05.003_bib25","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0140-6736(96)02149-6","article-title":"Effect of d-sotalol on mortality in patients with left ventricular dysfunction after recent and remote myocardial infarction","volume":"348","author":"Waldo","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.hroo.2024.05.003_bib26","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.jelectrocard.2014.10.005","article-title":"QTC intervals can be assessed with the AliveCor heart monitor in patients on dofetilide for atrial fibrillation","volume":"48","author":"Chung","year":"2015","journal-title":"J Electrocardiol"},{"key":"10.1016\/j.hroo.2024.05.003_bib27","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1111\/jce.12976","article-title":"Comparison of QT interval readings in normal sinus rhythm between a smartphone heart monitor and a 12-lead ECG for healthy volunteers and inpatients receiving sotalol or dofetilide","volume":"27","author":"Garabelli","year":"2016","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.1016\/j.hroo.2024.05.003_bib28","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1016\/j.japh.2022.05.028","article-title":"Evaluation of a program for outpatient sotalol loading with physician and pharmacist monitoring","volume":"62","author":"Roberts","year":"2022","journal-title":"J Am Pharm Assoc (2003)"},{"key":"10.1016\/j.hroo.2024.05.003_bib29","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1093\/ehjdh\/ztab034","article-title":"Antiarrhythmic drug loading at home using remote monitoring: a virtual feasibility study during COVID-19 social distancing","volume":"2","author":"Shah","year":"2021","journal-title":"Eur Heart J Digit Health"},{"key":"10.1016\/j.hroo.2024.05.003_bib30","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/j.jacep.2020.04.001","article-title":"Multilead QT screening is necessary for QT measurement: implications for management of patients in the COVID-19 era","volume":"6","author":"Cheung","year":"2020","journal-title":"Clin Electrophysiol"},{"key":"10.1016\/j.hroo.2024.05.003_bib31","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1177\/1074248420921740","article-title":"Assessment of sotalol and dofetilide dosing at\u00a0a\u00a0large academic medical center","volume":"25","author":"Ting","year":"2020","journal-title":"J Cardiovasc Pharmacol Ther"},{"key":"10.1016\/j.hroo.2024.05.003_bib32","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1177\/1074248419887710","article-title":"Multicenter analysis of dosing protocols for sotalol initiation","volume":"25","author":"Biswas","year":"2020","journal-title":"J Cardiovasc Pharmacol Ther"},{"key":"10.1016\/j.hroo.2024.05.003_bib33","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.hrcr.2019.04.005","article-title":"Outpatient intravenous sotalol load to replace 3-day admission oral sotalol load","volume":"5","author":"Von Bergen","year":"2019","journal-title":"HeartRhythm Case Rep"},{"key":"10.1016\/j.hroo.2024.05.003_bib34","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.jacep.2022.11.026","article-title":"Feasibility and safety of intravenous sotalol loading in adult patients with atrial fibrillation (DASH-AF)","volume":"9","author":"Lakkireddy","year":"2023","journal-title":"JACC Clin Electrophysiol"},{"key":"10.1016\/j.hroo.2024.05.003_bib35","doi-asserted-by":"crossref","unstructured":"Steinberg BA, Holubkov R, Deering T, et\u00a0al. Expedited loading with intravenous sotalol is safe and feasible\u2014primary results of the Prospective Evaluation Analysis and Kinetics of IV Sotalol (PEAKS) Registry [published online ahead of print February 28, 2024]. Heart Rhythm. doi:10.1016\/j.hrthm.2024.02.046.","DOI":"10.1016\/j.hrthm.2024.02.046"},{"key":"10.1016\/j.hroo.2024.05.003_bib36","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1161\/CIR.0000000000001193","article-title":"2023 ACC\/AHA\/ACCP\/HRS Guideline for the diagnosis and management of atrial fibrillation: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"149","author":"Joglar","year":"2024","journal-title":"Circulation"}],"container-title":["Heart Rhythm O2"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666501824001478?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666501824001478?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,20]],"date-time":"2024-06-20T08:18:55Z","timestamp":1718871535000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666501824001478"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":35,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["S2666501824001478"],"URL":"https:\/\/doi.org\/10.1016\/j.hroo.2024.05.003","relation":{},"ISSN":["2666-5018"],"issn-type":[{"value":"2666-5018","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Safety of outpatient commencement of sotalol","name":"articletitle","label":"Article Title"},{"value":"Heart Rhythm O2","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hroo.2024.05.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown Copyright \u00a9 2024 Published by Elsevier Inc. on behalf of Heart Rhythm Society.","name":"copyright","label":"Copyright"}]}}